CA2660178C - Promiscuous her-2/neu cd4 t cell epitopes - Google Patents

Promiscuous her-2/neu cd4 t cell epitopes Download PDF

Info

Publication number
CA2660178C
CA2660178C CA2660178A CA2660178A CA2660178C CA 2660178 C CA2660178 C CA 2660178C CA 2660178 A CA2660178 A CA 2660178A CA 2660178 A CA2660178 A CA 2660178A CA 2660178 C CA2660178 C CA 2660178C
Authority
CA
Canada
Prior art keywords
peptide
cell
seq
antigen
neu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2660178A
Other languages
English (en)
French (fr)
Other versions
CA2660178A1 (en
Inventor
Jami B. Wollan
Lori A. Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendreon Pharmaceuticals LLC
Original Assignee
Dendreon Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dendreon Pharmaceuticals LLC filed Critical Dendreon Pharmaceuticals LLC
Publication of CA2660178A1 publication Critical patent/CA2660178A1/en
Application granted granted Critical
Publication of CA2660178C publication Critical patent/CA2660178C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA2660178A 2006-08-11 2007-08-10 Promiscuous her-2/neu cd4 t cell epitopes Active CA2660178C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83720906P 2006-08-11 2006-08-11
US60/837,209 2006-08-11
US11/836,645 US7972602B2 (en) 2006-08-11 2007-08-09 Promiscuous HER-2/Neu CD4 T cell epitopes
US11/836,645 2007-08-09
PCT/US2007/075681 WO2008022019A2 (en) 2006-08-11 2007-08-10 Promiscuous her-2/neu cd4 t cell epitopes

Publications (2)

Publication Number Publication Date
CA2660178A1 CA2660178A1 (en) 2008-02-21
CA2660178C true CA2660178C (en) 2019-04-02

Family

ID=39082993

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2660178A Active CA2660178C (en) 2006-08-11 2007-08-10 Promiscuous her-2/neu cd4 t cell epitopes

Country Status (8)

Country Link
US (3) US7972602B2 (https=)
EP (2) EP2570422B1 (https=)
JP (1) JP5189593B2 (https=)
CA (1) CA2660178C (https=)
ES (2) ES2441252T3 (https=)
HU (1) HUE026977T2 (https=)
PL (1) PL2570422T3 (https=)
WO (1) WO2008022019A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017096247A1 (en) * 2015-12-04 2017-06-08 Mayo Foundation For Medical Education And Research Methods and vaccines for inducing immune responses to multiple different mhc molecules
US12247053B2 (en) 2018-10-26 2025-03-11 Saint Louis University Peptides for inducing heterosubtypic influenza T cell responses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673641A (en) 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
US5552534A (en) 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
US5550251A (en) 1991-12-12 1996-08-27 The Trustees Of The University Of Pennsylvania Alicyclic peptidomimetics
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US6160089A (en) 1998-07-08 2000-12-12 Mitsui Chemicals, Inc. Method for secretory production of human growth hormone
US7060284B1 (en) * 1999-08-03 2006-06-13 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
AU2087401A (en) 1999-12-10 2001-06-18 Epimmune, Inc. Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
WO2001074855A2 (en) * 2000-03-30 2001-10-11 Dendreon Corporation Compositions and methods for dendritic cell-based immunotherapy
US20040121946A9 (en) * 2000-12-11 2004-06-24 John Fikes Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
WO2005007694A1 (ja) * 2003-07-16 2005-01-27 Green Peptide Co., Ltd. ＨＥＲ２／ｎｅｕペプチドおよびその治療上の用途
GB0427131D0 (en) * 2004-12-10 2005-01-12 Glaxosmithkline Biolog Sa Novel combination

Also Published As

Publication number Publication date
US20080107667A1 (en) 2008-05-08
US8263757B2 (en) 2012-09-11
WO2008022019A3 (en) 2008-10-09
CA2660178A1 (en) 2008-02-21
US8658177B2 (en) 2014-02-25
US7972602B2 (en) 2011-07-05
EP2054430B1 (en) 2013-10-02
EP2054430A4 (en) 2010-02-17
US20110236967A1 (en) 2011-09-29
EP2054430A2 (en) 2009-05-06
JP5189593B2 (ja) 2013-04-24
ES2441252T3 (es) 2014-02-03
EP2570422A3 (en) 2013-07-10
US20120308513A1 (en) 2012-12-06
JP2010501160A (ja) 2010-01-21
PL2570422T3 (pl) 2016-09-30
EP2570422A2 (en) 2013-03-20
WO2008022019A2 (en) 2008-02-21
ES2561677T3 (es) 2016-02-29
HUE026977T2 (en) 2016-08-29
EP2570422B1 (en) 2015-12-16

Similar Documents

Publication Publication Date Title
JP3491896B2 (ja) 免疫調節ペプチド
EP0671926B1 (en) Immunomodulatory peptides
US8647865B2 (en) Promiscuous PAP CD4 T cell epitopes
WO1994004171A9 (en) Immunomodulatory peptides
AU2014346537A1 (en) Methods of using interleukin-10 for treating diseases and disorders
JP2007528422A (ja) 自己免疫疾患に関与する自己抗原および非自己抗原の同定
CA2456196A1 (en) Compositions and methods for modulation of immune responses
CN113179631A (zh) 通过临近使能反应疗法开发的共价蛋白质药物
EP3380505B1 (en) Peptides derived from achaete-scute homolog 2 (ascl2), complexes comprising such peptides bound to mhc molecules
JP4299777B2 (ja) 免疫応答を誘導するための方法および組成物
JPWO2001011044A1 (ja) 腫瘍抗原
CA2660178C (en) Promiscuous her-2/neu cd4 t cell epitopes
EP3974443A2 (en) Peptides derived from melanoma-associated antigen b2 (mageb2)
EP3380513A1 (en) Peptides from npsr1
CN114524870A (zh) 源自于ssx2抗原的短肽
CN108997481B (zh) 源自于lmp1的抗原短肽
CN110862449A (zh) 衍生自ssx的肿瘤抗原短肽

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240724

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240726

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250709

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250709